nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute apenditis in patient with acute promyelocytic leukemia
|
Papageorgiou, Sotirios G. |
|
2011 |
35 |
1 |
p. e4-e5 nvt p. |
artikel |
2 |
Alloreactive natural killer cells in hematopoietic stem cell transplantation
|
Pegram, Hollie J. |
|
2011 |
35 |
1 |
p. 14-21 8 p. |
artikel |
3 |
Antiangiogenic therapy accelerates tumor metastasis
|
Ribatti, Domenico |
|
2011 |
35 |
1 |
p. 24-26 3 p. |
artikel |
4 |
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
|
Estabragh, Zahra Raisi |
|
2011 |
35 |
1 |
p. 49-51 3 p. |
artikel |
5 |
Are SRC family kinases responsible for imatinib- and dasatinib-resistant chronic myeloid leukemias?
|
Chen, Yaoyu |
|
2011 |
35 |
1 |
p. 27-29 3 p. |
artikel |
6 |
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
|
Kimura, Shun-ichi |
|
2011 |
35 |
1 |
p. e11-e12 nvt p. |
artikel |
7 |
Cardiotoxicity of imatinib: At the heart of the problem
|
Tiribelli, Mario |
|
2011 |
35 |
1 |
p. 36-37 2 p. |
artikel |
8 |
Combined measurement of plasma cell proliferative and apoptotic index in multiple myeloma defines patients with good and poor prognosis
|
Minarik, Jiri |
|
2011 |
35 |
1 |
p. 44-48 5 p. |
artikel |
9 |
Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study
|
Xiao, Zhijian |
|
2011 |
35 |
1 |
p. 61-65 5 p. |
artikel |
10 |
3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase
|
Raynal, Noël J.-M. |
|
2011 |
35 |
1 |
p. 110-118 9 p. |
artikel |
11 |
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF
|
Smith, B. Douglas |
|
2011 |
35 |
1 |
p. 87-94 8 p. |
artikel |
12 |
Editorial Board
|
|
|
2011 |
35 |
1 |
p. CO2- 1 p. |
artikel |
13 |
Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains
|
Chang, Hong |
|
2011 |
35 |
1 |
p. 95-98 4 p. |
artikel |
14 |
Introduction to an occasional series
|
Bowen, David T. |
|
2011 |
35 |
1 |
p. 1-2 2 p. |
artikel |
15 |
Is imatinib-related cardiotoxicity still an open issue?
|
Breccia, Massimo |
|
2011 |
35 |
1 |
p. 34-35 2 p. |
artikel |
16 |
KIAA1524: A novel MLL translocation partner in acute myeloid leukemia
|
Coenen, Eva A. |
|
2011 |
35 |
1 |
p. 133-135 3 p. |
artikel |
17 |
Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients
|
Hayette, Sandrine |
|
2011 |
35 |
1 |
p. 38-43 6 p. |
artikel |
18 |
Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome
|
Tabouret, Emeline |
|
2011 |
35 |
1 |
p. 136- 1 p. |
artikel |
19 |
MPN-associated myelofibrosis (MPN-MF)
|
Mesa, R.A. |
|
2011 |
35 |
1 |
p. 12-13 2 p. |
artikel |
20 |
Mutational analysis of EZH2 codon 641 in non-Hodgkin lymphomas and leukemias
|
Park, Sang Wook |
|
2011 |
35 |
1 |
p. e6-e7 nvt p. |
artikel |
21 |
NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
|
Conticello, Concetta |
|
2011 |
35 |
1 |
p. 52-60 9 p. |
artikel |
22 |
No mutation in the FOXP3 gene in acute leukemias
|
Kim, Min Sung |
|
2011 |
35 |
1 |
p. e10- 1 p. |
artikel |
23 |
On the assessment of dasatinib-induced autophagy in CLL
|
Krause, Günter |
|
2011 |
35 |
1 |
p. 137-138 2 p. |
artikel |
24 |
Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol
|
Haïat, Stéphanie |
|
2011 |
35 |
1 |
p. 66-72 7 p. |
artikel |
25 |
p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes
|
Amrein, Lilian |
|
2011 |
35 |
1 |
p. 99-102 4 p. |
artikel |
26 |
Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone
|
Nicolini, Franck E. |
|
2011 |
35 |
1 |
p. 80-86 7 p. |
artikel |
27 |
Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib
|
Valent, Jason N. |
|
2011 |
35 |
1 |
p. e1-e3 nvt p. |
artikel |
28 |
Renewed interest in myeloma tumor growth, or just one more method to assess proliferation?
|
Ely, Scott |
|
2011 |
35 |
1 |
p. 30-31 2 p. |
artikel |
29 |
Role of Rho-ROCK signaling in MOLT4 cells metastasis induced by CCL25
|
Zhang, Li |
|
2011 |
35 |
1 |
p. 103-109 7 p. |
artikel |
30 |
Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription
|
Brown, N.L. |
|
2011 |
35 |
1 |
p. 126-132 7 p. |
artikel |
31 |
Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?
|
Grimwade, David |
|
2011 |
35 |
1 |
p. 3-7 5 p. |
artikel |
32 |
The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cells
|
Schwarz, Kerstin |
|
2011 |
35 |
1 |
p. 119-125 7 p. |
artikel |
33 |
The role of p53 and autophagy in Dasatinib resistance of CLL lymphocytes
|
Pitini, Vincenzo V. |
|
2011 |
35 |
1 |
p. 32-33 2 p. |
artikel |
34 |
Transient marked increase in lymphocytosis during acute illness in chronic lymphocytic leukemia
|
Sandhu, Indermohan |
|
2011 |
35 |
1 |
p. e8-e9 nvt p. |
artikel |
35 |
Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes
|
Della Porta, Matteo G. |
|
2011 |
35 |
1 |
p. 22-23 2 p. |
artikel |
36 |
Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation
|
Shi, Cheng-jun |
|
2011 |
35 |
1 |
p. 73-79 7 p. |
artikel |
37 |
What are RBC-transfusion-dependence and -independence?
|
Gale, R.P. |
|
2011 |
35 |
1 |
p. 8-11 4 p. |
artikel |